IL310334A - Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders - Google Patents
Psychoactive medicines and their use for treating psychiatric and neurological conditions and disordersInfo
- Publication number
- IL310334A IL310334A IL310334A IL31033424A IL310334A IL 310334 A IL310334 A IL 310334A IL 310334 A IL310334 A IL 310334A IL 31033424 A IL31033424 A IL 31033424A IL 310334 A IL310334 A IL 310334A
- Authority
- IL
- Israel
- Prior art keywords
- disorders
- neurological conditions
- psychoactive drugs
- treat psychiatric
- psychiatric
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163230237P | 2021-08-06 | 2021-08-06 | |
| US202163240113P | 2021-09-02 | 2021-09-02 | |
| US202163255706P | 2021-10-14 | 2021-10-14 | |
| US202263325757P | 2022-03-31 | 2022-03-31 | |
| US202263328343P | 2022-04-07 | 2022-04-07 | |
| PCT/US2022/074369 WO2023015154A1 (en) | 2021-08-06 | 2022-08-01 | Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL310334A true IL310334A (en) | 2024-03-01 |
Family
ID=85156410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL310334A IL310334A (en) | 2021-08-06 | 2022-08-01 | Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders |
Country Status (10)
| Country | Link |
|---|---|
| US (6) | US11707446B2 (https=) |
| EP (1) | EP4380588A4 (https=) |
| JP (1) | JP2024530007A (https=) |
| KR (1) | KR20240072133A (https=) |
| AU (1) | AU2022325135A1 (https=) |
| CA (1) | CA3227360A1 (https=) |
| IL (1) | IL310334A (https=) |
| MX (1) | MX2024001654A (https=) |
| TW (1) | TW202327571A (https=) |
| WO (1) | WO2023015154A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024254190A2 (en) * | 2023-06-06 | 2024-12-12 | Transcend Therapeutics, Inc. | Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders |
| US12295937B2 (en) | 2021-08-06 | 2025-05-13 | Transcend Therapeutics, Inc. | Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders |
| US12343326B2 (en) | 2021-08-06 | 2025-07-01 | Transcend Therapeutics, Inc. | Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders |
| MX2024001654A (es) | 2021-08-06 | 2024-06-28 | Transcend Therapeutics Inc | Medicamentos psicoactivos y su uso para el tratamiento de enfermedades y trastornos psiquiatricos y neurologicos. |
| KR20240165982A (ko) * | 2022-03-31 | 2024-11-25 | 트랜센드 테라퓨틱스 인코퍼레이티드 | 향정신성 의약품과 정신 및 신경계 병태 및 장애를 치료하기 위한 이의 용도 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996039133A1 (en) * | 1995-06-06 | 1996-12-12 | Neurobiological Technologies, Inc. | Novel n-substituted-2-amino-3',4'-methylene-dioxypropiophenones |
| US8575194B1 (en) | 2004-08-31 | 2013-11-05 | Jack William Schultz | Treatment methods of cognitive, emotional and mental ailments and disorders |
| US20120108510A1 (en) | 2010-05-20 | 2012-05-03 | Emory University | Methods of improving behavioral therapies |
| EP2931291B1 (en) | 2012-12-11 | 2021-10-20 | The McLean Hospital Corporation | Xenon treatment as an adjunct to psychotherapy for psychiatric disorders |
| WO2017151980A1 (en) | 2016-03-03 | 2017-09-08 | Segreti Louis M | Cannabis-based bioactive formulations and methods for use thereof |
| WO2021257500A1 (en) | 2020-06-17 | 2021-12-23 | Lobe Sciences Ltd. | Methods and compositions for treating mild traumatic brain injury, post-traumatic stress disorder and mild traumatic brain injury with post traumatic stress disorder |
| JP2024512796A (ja) * | 2021-04-01 | 2024-03-19 | テラン バイオサイエンシーズ インク． | サイケデリック薬およびセロトニン受容体調節因子に関する方法と組成物 |
| MX2024001654A (es) | 2021-08-06 | 2024-06-28 | Transcend Therapeutics Inc | Medicamentos psicoactivos y su uso para el tratamiento de enfermedades y trastornos psiquiatricos y neurologicos. |
| EP4426685A4 (en) * | 2021-11-05 | 2026-01-07 | Terran Biosciences Inc | Isotopic salts, crystalline forms, stereoisomers of methylone and ethylone and their methods of use |
-
2022
- 2022-08-01 MX MX2024001654A patent/MX2024001654A/es unknown
- 2022-08-01 IL IL310334A patent/IL310334A/en unknown
- 2022-08-01 JP JP2024506546A patent/JP2024530007A/ja active Pending
- 2022-08-01 AU AU2022325135A patent/AU2022325135A1/en active Pending
- 2022-08-01 CA CA3227360A patent/CA3227360A1/en active Pending
- 2022-08-01 WO PCT/US2022/074369 patent/WO2023015154A1/en not_active Ceased
- 2022-08-01 KR KR1020247007349A patent/KR20240072133A/ko active Pending
- 2022-08-01 EP EP22854040.7A patent/EP4380588A4/en active Pending
- 2022-08-05 TW TW111129588A patent/TW202327571A/zh unknown
- 2022-08-15 US US17/887,962 patent/US11707446B2/en active Active
-
2023
- 2023-06-28 US US18/215,547 patent/US12059402B2/en active Active
- 2023-11-02 US US18/386,337 patent/US11969407B2/en active Active
-
2024
- 2024-05-09 US US18/659,413 patent/US12233046B2/en active Active
-
2025
- 2025-01-16 US US19/024,616 patent/US20250255846A1/en active Pending
- 2025-12-04 US US19/409,215 patent/US20260083699A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20240058301A1 (en) | 2024-02-22 |
| WO2023015154A1 (en) | 2023-02-09 |
| US20240293357A1 (en) | 2024-09-05 |
| EP4380588A1 (en) | 2024-06-12 |
| US11969407B2 (en) | 2024-04-30 |
| US20230054211A1 (en) | 2023-02-23 |
| TW202327571A (zh) | 2023-07-16 |
| US12059402B2 (en) | 2024-08-13 |
| US20250255846A1 (en) | 2025-08-14 |
| CA3227360A1 (en) | 2023-02-09 |
| KR20240072133A (ko) | 2024-05-23 |
| US11707446B2 (en) | 2023-07-25 |
| JP2024530007A (ja) | 2024-08-14 |
| US12233046B2 (en) | 2025-02-25 |
| EP4380588A4 (en) | 2025-10-08 |
| US20260083699A1 (en) | 2026-03-26 |
| MX2024001654A (es) | 2024-06-28 |
| US20230338333A1 (en) | 2023-10-26 |
| AU2022325135A1 (en) | 2024-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL310334A (en) | Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders | |
| IL280710A (en) | Methods and compositions for treating mitochondrial disease or disorders and heteroplasmy | |
| IL290455A (en) | Methods of treating psychological and brain disorders | |
| PL3673080T3 (pl) | Oligomery antysensowne do leczenia stanów i chorób | |
| CU20160151A7 (es) | 2-AMIN0-6-METI L-4,4a, 5,6-TETRAHIDROPIRANO[3,4-d][1,3]TIAZIN-8a(8H)-IL-1,3-TIAZOL-4-ILAMIDAS | |
| IL262608A (en) | Combination treatment of ocular inflammatory disorders and diseases | |
| MX2019012818A (es) | Metodos para mejorar la memoria y la cognicion y para el tratamiento de trastornos de la memoria y cognitivos. | |
| IL304324A (en) | Heterocycle derivatives for treating trpm3 mediated disorders | |
| EP3813806A4 (en) | Methods of treating mitochondrial dysfunction | |
| MA43532A (fr) | Méthodes et compositions destinés au traitement de troubles liés à des crises épileptiques | |
| EP3307260A4 (en) | DIARYL AND ARYLHETEROARYL UREA DERIVATIVES FOR PROPHYLAXIS AND TREATMENT OF SLEEP BEHAVIORAL DISORDERS IN THE REM PHASE | |
| EP3566055C0 (en) | SCD INHIBITORS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS | |
| EP3672587A4 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF EYE DISEASES | |
| IL287748A (en) | Treatment and detection of inherited neuropathies and associated disorders | |
| EP3826650A4 (en) | METHODS OF TREATMENT OF NEUROLOGICAL DISEASES | |
| IL286268A (en) | Pridopidine for use in the treatment of mitochondrial associated diseases and disorders, including symptoms thereof | |
| EP3581175A4 (en) | PREPARATION FOR THE ADMINISTRATION OF A DRUG FOR THE TREATMENT OF MENTAL ILLNESSES OR CENTRAL NERVOUS SYSTEM DISORDERS | |
| PL3956310T3 (pl) | <div>MODYFIKOWANE POCHODNE AMINOKWASÓW DO LECZENIA CHORÓB NEUROLOGICZNYCH I WYBRANYCH ZABURZEŃ PSYCHICZNYCH</div> | |
| BR112017025263A2 (pt) | método para o tratamento de doença neurológica | |
| KR102591782B9 (ko) | 뇌신경계질환 예방 또는 치료용 약학적 조성물 | |
| IL263080B (en) | Treatment of neurological disorders | |
| EP3634370A4 (en) | TREATMENT OF SKIN DISEASES | |
| MA47595A (fr) | Méthodes de traitement d'affections neurodégénératives | |
| GB201914034D0 (en) | Treatment of neurological disorders | |
| EP3373888A4 (en) | METHOD FOR THE TREATMENT OF SKIN DISEASES USING PLASMONIC NANOPARTICLES |